Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD . Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback